Edmund Przegaliński

Author

Edmund Przegaliński

Also Known As

E PRZEGALINSKI, E Przegalinski, E Przegaliñski, E Przegaliński, E Przegaliṅski, E. PRZEGALINSKI, E. PRZEGALIŃSKI, E. Przegalinski, E. Przegaliñski, E. Przegaliński

265

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Maj Institute of Pharmacology Polish Academy of Sciences

About

Edmund Przegaliński is an author at Maj Institute of Pharmacology specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	85	3.5K
2	Social Sciences	27	49	2.1K
3	Health Sciences	12	14	557
4	Public Health	2	2	49
5	Natural Sciences	1	1	193

Edmund Przegaliński

Publications

Citations

H-Index

Page 1

	Year	Citations
Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo Chris G. Parsons, G. Quack, I. Bresink, Neuropharmacology Motor Impairment ActivityNeurophysiologyMedicineNeurotransmitterNeuropharmacology	1995	309
Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. Chris G. Parsons, Wojciech Danysz, G. Quack, PubMed NeurotransmitterPharmacotherapyExperimental PharmacologyGlycineb AntagonistsActive Antagonists	1997	193
Activation of endocannabinoid transmission induces antidepressant-like effects in rats. Przemysław Adamczyk, Anna Gołda, Andrew C. McCreary, PubMed PsychopharmacologyPharmacotherapyCannabinoid PharmacologyEcb SystemSocial Sciences	2008	123
The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats Przemysław Adamczyk, Joanna Miszkiel, Andrew C. McCreary, Brain Research Cannabis UseSubstance AbusePsychoactive DrugSubstance UseBehavioral Neuroscience	2012	112
The serotonergic system and its role in cocaine addiction. Małgorzata Filip, Małgorzata Frankowska, Magdalena Zaniewska, PubMed	2006	110
Antidepressant-like Effects of a Partial Agonist at Strychnine-insensitive Glycine Receptors and a Competitive NMDA Receptor Antagonist Edmund Przegaliński, E Tatarczyńska, A Dereń-Wesołek, Neuropharmacology Partial AgonistPsychiatryFunctional SelectivityAntidepressant-like EffectsStrychnine-insensitive Glycine Receptors	1997	108
Effects of GABAB receptor ligands in animal tests of depression and anxiety. Małgorzata Frankowska, Małgorzata Filip, Edmund Przegaliński PubMed	2008	104
The role of nitric oxide in chemically- and electrically-induced seizures in mice Edmund Przegaliński, L Baran, J Siwanowicz Neuroscience Letters NeurophysiologyNitric OxideSynaptic TransmissionMedicineNeurotransmitter	1996	101
Novel Systemically Active Antagonists of the Glycine Site of the N-Methyl-d-aspartate Receptor: Electrophysiological, Biochemical and Behavioral Characterization Chris G. Parsons, Wojciech Danysz, G. Quack, Journal of Pharmacology and Experimental Therapeutics Behavioral CharacterizationGlycine SiteMolecular PhysiologyBiochemistryFunctional Selectivity	1997	95
Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine Małgorzata Filip, Małgorzata Frankowska, Magdalena Zaniewska, Brain Research Psychoactive DrugNeurophysiologyAddictionMedicinePhysiology	2006	86

Page 1